title: Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong.
abstract: Many healthcare workers were infected while looking after the SARS patients on the medical wards in 2003. The high infectivity of the SARS coronavirus with peak viral load on day 10 of illness when patients were ill, overcrowding of the old medical wards with low air changes/hr (ACH), and aerosol-generating procedures while resuscitating the patients were the major factors. Procedures reported to present an increased risk of SARS transmission include tracheal intubation, non-invasive ventilation, tracheotomy and manual ventilation before intubation whereas oxygen therapy and bed distance <1 m were also implicated. Studies based on laser visualization technique with smoke particles as smokers in the human patient simulator has shown that oxygen therapy via Hudson mask and nasal cannula could disperse exhaled air of patients to 0.4 and 1 m respectively whereas jet nebulizer could disperse exhaled air >0.8 m from the patient. Bigger isolation rooms with 16 ACH are more effective than smaller isolation rooms with 12 ACH in removing exhaled air and preventing room contamination but at the expense of more noise and electricity consumption. Non-invasive ventilation via face masks and single circuit can disperse exhaled air from 0.4 to 1 m. Both higher inspiratory pressures and use of whisper swivel device (to facilitate carbon dioxide removal) could increase the exhaled air leakage and isolation room contamination during on-invasive ventilation. Addition of a viral-bacterial filter during manual ventilation by bagging may reduce the exhaled air leakage forward and yet increase the sideway leakage. N95 mask was more effective than surgical mask in preventing expelled air leakage during patient's coughing but there was still significant sideway leakage to 15 cm. Clinicians should be aware of air leakage from the various face masks and adopt strict infection control measures during resuscitation of patients with severe respiratory infections. Carefully designed clinical trials are required to determine the optimal timing and dosage of any antiviral agents, convalescent plasma, and immuno-modulating agents in the treatment of the possibly immune-mediated lung injury in SARS and newly emerged infection such as the Middle East Respiratory Syndrome.
authors: Division of Respiratory Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.
authors: David S
authors: DS
authors: Hui
keywords: Middle East Respiratory Syndrome (MERS); Severe acute respiratory syndrome (SARS); lessons; management
references: Clin Infect Dis. 2006 Jul 1;43(1):e1-5
references: 16758408
references: Clin Microbiol Infect. 2004 Jul;10(7):676-8
references: 15214887
references: Radiology. 2005 Apr;235(1):168-75
references: 15703312
references: Clin Infect Dis. 2007 Apr 15;44(8):1017-25
references: 17366443
references: Lancet. 2003 Oct 25;362(9393):1353-8
references: 14585636
references: Biochem Biophys Res Commun. 2005 Jan 28;326(4):905-8
references: 15607755
references: Emerg Infect Dis. 2004 Apr;10(4):581-6
references: 15200845
references: Chest. 2006 Sep;130(3):730-40
references: 16963670
references: Clin Radiol. 2004 Jul;59(7):602-8
references: 15208066
references: Chest. 2009 Mar;135(3):648-654
references: 19265085
references: N Engl J Med. 2003 May 15;348(20):1977-85
references: 12671062
references: Hong Kong Med J. 2003 Dec;9(6):399-406
references: 14660806
references: JAMA. 2003 Dec 24;290(24):3222-8
references: 14693875
references: J Clin Virol. 2004 Dec;31(4):304-9
references: 15494274
references: Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7
references: 15657466
references: JAMA. 2003 Jun 4;289(21):2801-9
references: 12734147
references: Chest. 2003 Jul;124(1):12-5
references: 12853495
references: Clin Infect Dis. 2011 Feb 15;52(4):447-56
references: 21248066
references: Chest. 2006 Sep;130(3):822-6
references: 16963681
references: Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6
references: 15616839
references: Clin Infect Dis. 2010 Nov 15;51(10):1176-83
references: 20942655
references: Thorax. 2004 May;59(5):414-20
references: 15115870
references: N Engl J Med. 2003 Jul 31;349(5):507-8
references: 12890854
references: PLoS One. 2012;7(12):e50845
references: 23239991
references: N Engl J Med. 2013 Jun 27;368(26):2487-94
references: 23718156
references: N Engl J Med. 2003 May 15;348(20):1986-94
references: 12682352
references: Lancet. 2003 May 24;361(9371):1767-72
references: 12781535
references: N Engl J Med. 2012 Nov 8;367(19):1814-20
references: 23075143
references: Radiology. 2003 Aug;228(2):395-400
references: 12738877
references: Radiology. 2004 Nov;233(2):579-85
references: 15375225
references: Emerg Infect Dis. 2003 Nov;9(11):1381-7
references: 14718079
references: Lancet. 2003 Jul 26;362(9380):293-4
references: 12892961
references: Virology. 2004 Nov 10;329(1):11-7
references: 15476870
references: Lancet. 2013 Jun 29;381(9885):2265-72
references: 23727167
references: Am J Respir Crit Care Med. 2013 Apr 1;187(7):e12-4
references: 23540885
references: J Infect. 2004 Nov;49(4):262-73
references: 15474623
references: Thorax. 2004 Mar;59(3):252-6
references: 14985565
references: Emerg Infect Dis. 2004 Feb;10(2):317-9
references: 15030704
references: Antiviral Res. 2013 Jun;98(3):410-6
references: 23578727
references: Respirology. 2011 Aug;16(6):1005-13
references: 21605275
references: J Clin Pathol. 2004 Mar;57(3):260-5
references: 14990596
references: Emerg Infect Dis. 2004 Feb;10(2):339-41
references: 15030708
references: Chest. 2007 Aug;132(2):540-6
references: 17573505
references: PLoS One. 2012;7(4):e35797
references: 22563403
references: Emerg Infect Dis. 2005 Dec;11(12):1860-5
references: 16485471
references: Nat Med. 2004 Mar;10(3):290-3
references: 14981511
references: J Infect Dis. 2004 Apr 1;189(7):1164-7
references: 15031783
references: Emerg Infect Dis. 2003 Jun;9(6):713-7
references: 12781012
references: Chest. 2009 Oct;136(4):998-1005
references: 19411297
references: Clin Exp Immunol. 2004 Apr;136(1):95-103
references: 15030519
references: J Clin Virol. 2004 Sep;31(1):69-75
references: 15288617